Search

Brad S Shumel

from Dobbs Ferry, NY
Age ~62
Get Report
Also known as:
Brad Margaret Shumel, Brad S Shunel, Margaret Shumel
Related to:
Margaret A ShumelRhoda Shumel, 94Dorothy ShumelBrooke M ShumelPauline T Hancsarik, 81Lawrence A Shumel, 69Richard A Ceisler, 69
Connected to:
Alexander A Shumicki, 70Kara N Shumila, 38Marie C Shumilak, 61Matthew A Shumiloff, 35Olga A Shumilova, 75Michael V Shuminov, 66Bryan J Shumock, 67Amy J Shumoski, 46Leah I Shumoski, 41

Brad Shumel Phones & Addresses

  • Dobbs Ferry, NY
  • 6 Brittany Ct, Chappaqua, NY 10514
  • Mahopac, NY
  • White Plains, NY
  • Buffalo, NY
  • Hemet, CA
  • Carmel, NY

Work

Company: Boehringer ingelheim pharmaceuticals Position: Senior associate director

Languages

English

Industries

Pharmaceuticals

Specialities

Obstetrics & Gynecology • Gynecology

Professional Records

Medicine Doctors

Brad Shumel Photo 1

Dr. Brad Shumel, Chappaqua NY - MD (Doctor of Medicine)

View page
Specialties:
Obstetrics & Gynecology
Gynecology
Address:
6 Brittany Ct, Chappaqua, NY 10514
(914) 239-4919 (Phone)
Languages:
English
Brad Shumel Photo 2

Brad Stuart Shumel

View page
Specialties:
Obstetrics & Gynecology
Education:
State University of New York at Buffalo (1988)

Resumes

Resumes

Brad Shumel Photo 3

Senior Associate Director At Boehringer Ingelheim Pharmaceuticals

View page
Position:
Senior Associate Director at Boehringer Ingelheim Pharmaceuticals
Location:
Greater New York City Area
Industry:
Pharmaceuticals
Work:
Boehringer Ingelheim Pharmaceuticals
Senior Associate Director

Business Records

Name / Title
Company / Classification
Phones & Addresses
Brad Stuart Shumel
Brad Shumel MD
616 Clock Tower Commons, Brewster, NY 10509

Publications

Us Patents

Methods Comprising Desmopressin

View page
US Patent:
20090291880, Nov 26, 2009
Filed:
May 21, 2009
Appl. No.:
12/469801
Inventors:
Bjarke Mimer Klein - Frederiksberg, DK
Jens Peter Norgaard - Frederiksberg, DK
Brad Shumel - Chappaqua NY, US
International Classification:
A61K 38/12
US Classification:
514 9
Abstract:
The present disclosure is directed to gender, age, and dose effects of desmopressin on reducing nocturnal voids, increasing an initial period of undisturbed sleep, and/or reducing nocturnal urine volume.

Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R Inhibitor

View page
US Patent:
20200246416, Aug 6, 2020
Filed:
Jul 16, 2019
Appl. No.:
16/513285
Inventors:
- Tarrytown NY, US
- Paris, FR
BOLANLE AKINLADE - WHITE PLAINS NY, US
GIANLUCA PIROZZI - BRIDGEWATER NJ, US
XING SUN - BRIDGEWATER NJ, US
THOMAS HULTSCH - BRIDGEWATER NJ, US
BRAD S. SHUMEL - Chappaqua NY, US
ASHISH BANSAL - WHITE PLAINS NY, US
International Classification:
A61K 38/02
C07K 16/28
A61P 17/00
A61K 45/06
C07K 16/24
C07K 7/06
A61K 9/00
Abstract:
The present invention provides methods for treating moderate-to-severe or severe atopic dermatitis (AD). The methods of the present invention comprise administering to a subject in need thereof one or more doses of an interleukin-4 receptor (IL-4R) inhibitor such as an anti-IL-4R antibody. In certain embodiments, the methods of the present invention are used to treat severe AD in a patient whose disease is not controlled with systemic therapy (e.g., cyclosporine A) or when such therapy is inadvisable.

Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R Inhibitor

View page
US Patent:
20180078603, Mar 22, 2018
Filed:
Sep 21, 2017
Appl. No.:
15/711815
Inventors:
- Tarrytown NY, US
- Paris, FR
Bolanle AKINLADE - White Plains NY, US
Gianluca PIROZZI - Bridgewater NJ, US
Xing SUN - Bridgewater NJ, US
Thomas HULTSCH - Bridgewater NJ, US
Brad S. SHUMEL - Chappaqua NY, US
Ashish BANSAL - White Plains NY, US
International Classification:
A61K 38/02
A61K 9/00
C07K 7/06
C07K 16/24
Abstract:
The present invention provides methods for treating moderate-to-severe or severe atopic dermatitis (AD). The methods of the present invention comprise administering to a subject in need thereof one or more doses of an interleukin-4 receptor (IL-4R) inhibitor such as an anti-IL-4R antibody. In certain embodiments, the methods of the present invention are used to treat severe AD in a patient whose disease is not controlled with systemic therapy (e.g., cyclosporine A) or when such therapy is inadvisable.
Control profile
Brad S Shumel from Dobbs Ferry, NY, age ~62 Get Report